Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

HCV-infected patients in the ED should be tested for advanced liver fibrosis

Yu-Hsiang Hsieh Y-H. Am J Emerg Med. 2019;37[2]:286-90

Key clinical point: An easy test for advanced liver fibrosis, FIB-4, should be used in all HCV-infected patients admitted to the ED.

Major finding: All-cause mortality for patients with advanced fibrosis was significantly higher than for those without (18.4% vs. 4.0%, P = .030).

Study details: Retrospective analysis of 113 HIV-infected patients admitted to the ED of a single institution.

Disclosures: The authors reported having no conflicts.


Yu-Hsiang Hsieh Y-H. Am J Emerg Med. 2019;37[2]:286-90.